» Articles » PMID: 20221656

Recent Developments in Innervation Imaging Using Iodine-123-metaiodobenzylguanidine Scintigraphy in Lewy Body Diseases

Overview
Journal Neurol Sci
Specialty Neurology
Date 2010 Mar 12
PMID 20221656
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Radiolabeled metaiodobenzylguanidine (MIBG) is an analog of guanethidine and is taken up by the postganglionic presynaptic nerve endings. MIBG uptake in the heart correlates with adrenergic function, which can be reduced in Lewy body diseases. We described the recent developments in innervation imaging using (123)I-MIBG scintigraphy in Lewy body diseases including Parkinson's disease and dementia with Lewy bodies. Particularly, we underlined the role of MIBG scintigraphy in differential diagnosis of movement disorders. As described by recent studies, MIBG scintigraphy is a valuable diagnostic tool for differentiation between Lewy body diseases and parkinsonian syndromes or other movement disorders with parkinsonism. Furthermore, this method may provide a powerful differential diagnostic tool between dementia with Lewy bodies and Alzheimer's disease. We also reported the results of clinical investigations about the correlation between characteristics of Parkinson's disease and myocardial MIBG uptake.

Citing Articles

Cardiovascular dysautonomia and cognitive impairment in Parkinson's disease (Review).

Khalil I, Sayad R, Kedwany A, Sayed H, Caprara A, Rissardo J Med Int (Lond). 2024; 4(6):70.

PMID: 39355336 PMC: 11443310. DOI: 10.3892/mi.2024.194.


The diagnostic performance of functional dopaminergic scintigraphic imaging in the diagnosis of dementia with Lewy bodies: an updated systematic review.

Jreige M, Kurian G, Perriraz J, Potheegadoo J, Bernasconi F, Stampacchia S Eur J Nucl Med Mol Imaging. 2023; 50(7):1988-2035.

PMID: 36920494 PMC: 10199865. DOI: 10.1007/s00259-023-06154-y.


Assessment of right ventricular sympathetic dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy: An I-metaiodobenzylguanidine SPECT/CT study.

Todica A, Siebermair J, Schiller J, Zacherl M, Fendler W, Massberg S J Nucl Cardiol. 2018; 27(6):2402-2409.

PMID: 30560521 PMC: 7749057. DOI: 10.1007/s12350-018-01545-3.


Roles of cardiac sympathetic neuroimaging in autonomic medicine.

Goldstein D, Cheshire Jr W Clin Auton Res. 2018; 28(4):397-410.

PMID: 30062642 PMC: 8917443. DOI: 10.1007/s10286-018-0547-6.


I-MIBG myocardial scintigraphy for the evaluation of Lewy body disease: are delayed images essential? Is visual assessment useful?.

Sakamoto F, Shiraishi S, Tsuda N, Ogasawara K, Yoshida M, Yuki H Br J Radiol. 2016; 89(1064):20160144.

PMID: 27222274 PMC: 5124887. DOI: 10.1259/bjr.20160144.


References
1.
Rascol O, Schelosky L . 123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders. Mov Disord. 2009; 24 Suppl 2:S732-41. DOI: 10.1002/mds.22499. View

2.
Braune S . The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes. Clin Auton Res. 2002; 11(6):351-5. DOI: 10.1007/BF02292766. View

3.
Hishikawa N, Hashizume Y, Yoshida M, Sobue G . Clinical and neuropathological correlates of Lewy body disease. Acta Neuropathol. 2003; 105(4):341-50. DOI: 10.1007/s00401-002-0651-4. View

4.
Miyamoto T, Miyamoto M, Suzuki K, Nishibayashi M, Iwanami M, Hirata K . 123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder. Sleep. 2008; 31(5):717-23. PMC: 2398741. DOI: 10.1093/sleep/31.5.717. View

5.
Courbon F, Brefel-Courbon C, Thalamas C, Alibelli M, Berry I, Montastruc J . Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease. Mov Disord. 2003; 18(8):890-7. DOI: 10.1002/mds.10461. View